These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11467313)

  • 1. Clinical chemistry and clinical toxicology devices advisory panel recommendation on Glucowatch.
    Klonoff DC
    Diabetes Technol Ther; 2000; 2(1):125-6. PubMed ID: 11467313
    [No Abstract]   [Full Text] [Related]  

  • 2. GlucoWatch approved for children with diabetes.
    FDA Consum; 2002; 36(6):6. PubMed ID: 12523287
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-invasive glucose monitoring device approved.
    Healthc Leadersh Manag Rep; 2001 Mar; 9(3):21. PubMed ID: 11329868
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA approves watch-like device to monitor blood sugar levels.
    Formanek R
    FDA Consum; 2001; 35(3):7. PubMed ID: 11458558
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA panel approves Cygnus's noninvasive GlucoWatch.
    Sage BH
    Diabetes Technol Ther; 2000; 2(1):115-6. PubMed ID: 11467309
    [No Abstract]   [Full Text] [Related]  

  • 6. Company gets a guilty reading in glucose monitor case.
    Meadows M
    FDA Consum; 2001; 35(2):38-9. PubMed ID: 11444248
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA clears two glucose test meters.
    FDA Consum; 2002; 36(5):8. PubMed ID: 12412542
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA Clinical Chemistry and Clinical Toxicology Devices Panel.
    Klonoff DC
    Diabetes Technol Ther; 1999; 1(2):201-2. PubMed ID: 11475293
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical devices; clinical chemistry and clinical toxicology devices; drug metabolizing enzyme genotyping system. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Mar; 70(46):11865-7. PubMed ID: 15762010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An "ouchless" future? Will the day come when you no longer have to prick, stick, jab or stab to check your glucose levels?
    Kordella T
    Diabetes Forecast; 2005 Apr; 58(4):51-3. PubMed ID: 15858899
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical devices; clinical chemistry and clinical toxicology devices; classification of the breath nitric oxide test system. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jul; 68(129):40125-7. PubMed ID: 12858842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical devices; clinical chemistry and clinical toxicology devices; instrumentation for clinical multiplex test systems. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Mar; 70(46):11867-9. PubMed ID: 15762011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical devices; clinical chemistry and clinical toxicology devices; classification of the cardiac allograft gene expression profiling test systems.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Oct; 74(202):53883-5. PubMed ID: 19877379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive glycaemia monitoring: background, traditional findings, and novelties in the recent clinical trials.
    Tura A
    Curr Opin Clin Nutr Metab Care; 2008 Sep; 11(5):607-12. PubMed ID: 18685457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical chemistry and clinical toxicology devices; classification of B-type natriuretic peptide test system. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2001 Feb; 66(40):12733-4. PubMed ID: 11503864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugar rush. Makers of continuous-monitoring devices for diabetics target hospitals.
    Mantone J
    Mod Healthc; 2006 Dec; 36(49):30, 32. PubMed ID: 17212224
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical devices; clinical chemistry and clinical toxicology devices; classification of newborn screening test systems for amino acids, free carnitine, and acylcarnitines using tandem mass spectrometry. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Nov; 69(226):68254-5. PubMed ID: 15562554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA Approval of Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: A Potentially Risky Decision.
    Shapiro AR
    JAMA; 2017 Oct; 318(16):1541-1542. PubMed ID: 28910454
    [No Abstract]   [Full Text] [Related]  

  • 19. Report from the meeting of the Circulatory System Devices Panel of the Food and Drug Administration Center for Devices and Radiologic Health: September 21, 2004.
    Maisel WH;
    Circulation; 2005 Apr; 111(16):2143-5. PubMed ID: 15851621
    [No Abstract]   [Full Text] [Related]  

  • 20. Noninvasive glucose-monitoring device gains FDA approval.
    Am J Health Syst Pharm; 2001 May; 58(10):854, 857. PubMed ID: 11381486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.